References
- Cecchi L, Melani F, Filacchioni G, Tredici M. Synthesis and biological activity of some 3-(pyrazol-1′-yl)indazole derivatives. Farmaco 1984;39:945–952.
- Ko JH, Yeon SW, Ryu JS, Yong KT, Ha SE, Jung YH, Eun PR, Kyu, RC. Synthesis and biological evaluation of 5-arylamino-6-chloro-1H-indazole-4,7-diones as inhibitors of protein kinase B/Akt. Bioorg Med Chem Lett 2006;16:6001–6005.
- Gerpe A, Aguirre G, Boiani L, Cerecetto H, Gonzalez M, Olea-Azar C, Rigol C, Maya JD, Morello A, Piro OE, Aran VJ, Azqueta A, de Cerain AL, Monge A, Rojas MA, Yaluff G. Indazole N-oxide derivatives as antiprotozoal agents: Synthesis, biological evaluation and mechanism of action studies. Bioorg Med Chem 2006;14:3467–3480.
- Li X, Chu S, Feher VA, Khalili M, Nie Z, Margosiak S, Nikulin V, Levin J, Sprankle KG, Tedder ME, Almassy R, Appelt K, Yager KM. Structure-Based design, synthesis, and antimicrobial activity of indazole-derived SAH/MTA nucleosidase Inhibitors. J Med Chem 2003;46:5663–5673.
- Selwood DL, Brummell DG, Budworth J, Burtin GE, Campbell RO, Chana S, Charles IG, Fernandez PA, Glen RC, Goggin MC, Hobbs AJ, Kling MR, Liu Q, Madge DJ, Meillerais S, Powell KL, Reynolds K, Spacey GD, Stables JN, Tatlock MA, Wheelers KA, Wishart G, Woo C. Synthesis and biological evaluation of novel pyrazoles and indazoles as activators of the nitric oxide receptor, soluble guanylate cyclase. J Med Chem 2001;44:78–93.
- Robert Finn. Male contraceptive methods are in the pipeline. Ob Gyn News 2007;42:28.
- Pelicano H, Martin DS, Xu RH, Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 2006;25:4633–4646.
- Southan GJ, Szabo C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 1996;51:383–394.
- Kimura Y, Hatanaka K, Naitou Y, Maeno K, Shimada I, Koakutsu A, Wanibuchi F, Yamaguchi T. Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist. Eur J Pharmacol 2004;483:37–43.
- May JA, Sharif NA, Chen HH, Liao JC, Kelly CR, Glennon RA, Young R, Li JX, Rice KC, France CP. Pharmacological properties and discriminative stimulus effects of a novel and selective 5-HT(2) receptor agonist AL-38022A [(S)-2-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine. Pharmacol Biochem Behaviour 2009;91:307–314.
- Gopalakrishnan M, Thanusu J, Kanagarajan V, Govindaraju R. Design, synthesis and in vitro microbiological evaluation of 6,6-dimethyl-7,9-diaryl-1,2,4,8-tetraazaspiro[4.5]decan-3-thiones - A new series of ‘tailor-made’ compounds. J Enz Inhib Med Chem 2009;24:406–412.
- Gopalakrishnan M, Thanusu J, Kanagarajan V. Synthesis and biological evaluation of 5,7-diaryl-4,4-dimethyl-4,5,6,7-tetrahydropyridino[3,4-d]-1,2,3-thiadiazoles. Med Chem Res 2007;16:392–401.
- Gopalakrishnan M, Sureshkumar P, Thanusu J, Kanagarajan V, Govindaraju R, Jayasri G. A convenient ‘one-pot’ synthesis and in vitro microbiological evaluation of novel 2,7-diaryl-[1,4]-diazepan-5-ones. J Enz Inhib Med Chem 2007;22:709–715.
- Gopalakrishnan M, Sureshkumar P, Thanusu J, Kanagarajan V. Synthesis, spectral analysis, antibacterial and antifungal activities of some 4,6-diaryl-4,5-dihydro-3-hydroxy-2[H]-indazole-A novel fused indazole derivative. J Enz Inhib Med Chem 2008;23:974–979.
- Gopalakrishnan M, Sureshkumar P, Kanagarajan V, Thanusu J. Design, ‘one-pot’ synthesis, characterization, antibacterial and antifungal activities of novel 6-aryl-1,2,4,5-tetrazinan-3-thiones in dry media. J Sulfur Chem 2007;28:383–392.
- Guthrie W, Wang XP. The aldol condensation of acetophenone with acetone. Can J Chem 1991; 69:339–344.
- Dhar MH, Dhar, MM, Dhawan BN, Mehrotra BN, Ray C. Screening of Indian plants biological activity. Part I. Indian J Exp Biol 1968;6:232–247.
- Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliver Rev 1997;23:3–25.
- Purser S, Moore PR, Swallow S, Gouverneur V. Fluorine in Medicinal Chemistry. Chem Soc Rev 2008;37:320–330.
- Sarmiento, R.M.R.; Nettekoven, M.H.; Taylor, S.; Plancher, J.M.; Roche, O. Selective naphthalene H3 receptor inverse agonists with reduced potential to induce phospholipidosis and their quinoline analogs. Bioorg Med Chem Lett 2009;19:4495–4500.